Journal article
Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene
J Tremblay, Y Wang, J Raelson, FC Marois-Blanchet, Z Wu, H Luo, E Bradley, J Chalmers, M Woodward, S Harrap, P Hamet, J Wu
Scientific Reports | NATURE PORTFOLIO | Published : 2017
DOI: 10.1038/srep44114
Open access
Abstract
EPH kinases and their ligands, ephrins (EFNs), have vital and diverse biological functions. We recently reported that Efnb3 gene deletion results in hypertension in female but not male mice. These data suggest that EFNB3 regulates blood pressure in a sex- and sex hormone-dependent way. In the present study, we conducted a human genetic study to assess the association of EFNB3 single nucleotide polymorphisms with human hypertension risks, using 3,448 patients with type 2 diabetes from the ADVANCE study (Action in Diabetes and Vascular Disease: Peterax and Diamicron MR Controlled Evaluation). We have observed significant association between 2 SNPs in the 3′ untranslated region or within the ad..
View full abstractGrants
Awarded by Fondation Jean-Louis Lévesque
Funding Acknowledgements
The authors thank Jerry Pelletier (Biochemistry, McGill) for help in analyzing RNA motifs in the 3' UTR of EFNB3. This work was supported by grants from the Canadian Institutes of Health Research to J.W. (MOP57697, MOP69089 and MOP 123389), H.L. (MOP97829), JT and P.H (ISO106797). It was also financed by grants from the Natural Sciences and Engineering Research Council of Canada (203906-2012), Juvenile Diabetes Research Foundation (17-2013-440), Fonds de recherche du Quebec-Sante (Ag-06) and the J.-Louis Levesque Foundation to J.W. It is financed also by grants from OPTI-THERA to J.T. and P.H.